
IDEX (IEX) Stock Forecast & Price Target
IDEX (IEX) Analyst Ratings
Bulls say
IDEX is well positioned by its recurring exposure to attractive niches in pumps, valves, fluidic systems, water, life science, and fire and safety, and its 2025 revenue of $3.5 billion gives it scale to compound earnings efficiently. The strongest fundamental driver is the acceleration in higher-growth platforms, especially HST, where 21% organic orders and 13% organic sales in 3Q26 helped lift consolidated organic sales 8%, orders 13%, and adjusted cash EPS to $2.33, while margins expanded to 27.8%. Its 80/20 operating discipline, cross-business innovation, positive price/cost, and strong free cash flow conversion above 100% support continued reinvestment, bolt-on M&A, and buybacks, while guidance increases for 2026 signal broadening demand and durable earnings momentum.
Bears say
IDEX is exposed to a fragile operating backdrop in which policy, tariff, and macro uncertainty can pressure its short-cycle industrial businesses and disrupt demand across material science solutions, space communication, and datacenter growth platforms. Weakness in general industrial spending, a prolonged inventory reset in higher-margin life science and agriculture-related end markets, and public funding volatility in municipal water, fire and rescue, and health and science technologies could all drive volume deleverage and compress cash generation. With $3.5 billion in revenue in 2025, the company also faces tariff-related cost pressure, FX headwinds, and execution risk from M&A, leaving upside dependent on growth-platform execution that appears uncertain.
This aggregate rating is based on analysts' research of IDEX and is not a guaranteed prediction by Public.com or investment advice.
IDEX (IEX) Analyst Forecast & Price Prediction
Start investing in IDEX (IEX)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About IDEX (IEX) Forecast
IDEX (IEX) Analyst Forecast & Price Prediction
Start investing in IDEX (IEX)
Order type
Buy in
Order amount
Est. shares
0 shares